|Agreement labeling||Emerald Premier|
|Has the agreement been disclosed and published?||Yes|
|Agreement period||01/01/2021 – 12/31/2023|
|Consortia / Institution||FinELib consortium|
Approximate range of annual corresponding author publications
|Comments on size/article output||Approximately 90% of articles will be covered OA on 2021. On years 2022 and 2023 agreement covers the whole publishing output.|
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions fully converted to OA publishing fees (access related costs 5% or less)|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||Yes|
|OA LICENSE||CC-BY mandatory|
||Original research articles
What is the approximate share of access related costs of the overall agreement?
|More than 50%|
|Comments on access costs||Access-related costs are not possible to separate from publishing cost|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|Comments on workflows||New workflow coming in 2021|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|